Ventral Hernia Treatment Market Forecast: What to Expect by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Ventral Hernia Treatment Market From 2025 To 2034?

The ventral hernia treatment market size has shown substantial growth in recent years. Its value is set to increase from $4.87 billion in 2024 to $5.22 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.2%. The expansion observed in prior periods is linked to the rising occurrence of obesity, enhanced understanding of ventral hernias, the expanding aging population, an increase in disposable income, and a greater demand for minimally invasive surgical interventions.

The ventral hernia treatment market is projected to experience substantial expansion over the coming years. It is anticipated to reach $6.84 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.0%. This projected growth during the forecast period stems from factors such as an increasing demand for outpatient procedures, greater expenditure on healthcare, expanding government initiatives, a heightened need for hernia repair surgeries, and increased investment in research and development. Key trends expected within the forecast timeframe encompass advanced hernia repair devices, the utilization of bioabsorbable materials, strategic collaborations, robotic-assisted surgical devices, and remote patient monitoring.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21315&type=smp

What Are The Drivers Pushing New Developments In The Ventral Hernia Treatment Market?

The increasing prevalence of obesity is anticipated to propel the growth of the ventral hernia treatment market going forward. Obesity is a medical condition characterized by an excessive amount of body fat that significantly impacts an individual’s health. This rising prevalence of obesity stems from factors such as poor diet, sedentary lifestyle, genetic factors, lack of physical activity, environmental influences, and emotional stress. Ventral hernia treatment supports obesity patients by addressing the complications arising from excessive weight, as it helps alleviate strain on the abdominal wall, reduces the risk of hernia recurrence, and enhances overall abdominal strength. This is crucial for promoting mobility and encouraging healthier lifestyle choices in individuals struggling with obesity. For instance, in March 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported that approximately one in eight people worldwide were struggling with obesity. This included 2.5 billion adults (aged 18 years and older) who were overweight, with 890 million of them living with obesity. Among adults, 43% were overweight, and 16% were classified as obese. Additionally, the number of overweight children under the age of 5 reached 37 million. Therefore, the increasing prevalence of obesity drives the ventral hernia treatment market.

What Are The Major Segment Categories Driving The Ventral Hernia Treatment Market Growth?

The ventral hernia treatmentmarket covered in this report is segmented –

1) By Type: Epigastric (Stomach Area) Hernia; Umbilical (Belly Button) Hernia; Incisional Hernia

2) By Diagnosis: Ultrasound; Computed Tomography (CT) Scan; Magnetic Resonance Imaging (MRI)

3) By Surgery: Open Hernia Surgery; Laparoscopic Surgery; Robotic Hernia Surgery

4) By End Users: Hospitals; Ambulatory Surgical Centres; Clinics

Subsegments:

1) By Epigastric (Stomach Area) Hernia: Small Epigastric Hernia; Large Epigastric Hernia

2) By Umbilical (Belly Button) Hernia: Congenital Umbilical Hernia; Acquired Umbilical Hernia

3) By Incisional Hernia: Primary Incisional Hernia; Recurrent Incisional Hernia

Which Competitive Trends Are Defining The Ventral Hernia Treatment Market Structure?

Leading firms within the ventral hernia treatment market prioritize technological innovations, such as laparoscopic and open hernia mesh fixation devices, aiming to elevate surgical results, mitigate complications, and accelerate patient recuperation. These devices are defined as medical instruments employed to fasten mesh during hernia repair operations, utilizing either minimally invasive (laparoscopic) or conventional open surgical techniques. An example is the launch in March 2024 by TELA Bio Inc., a US-based medical technology company, of its LIQUIFIX FIX8 laparoscopic and LIQUIFIX precision open hernia mesh fixation devices across the U.S. Specifically, LIQUIFIX FIX8 targets minimally invasive repairs, whereas LIQUIFIX precision is engineered for open femoral and inguinal hernia repairs. These FDA-approved tools utilize liquid anchors to attach mesh without tissue penetration, thereby diminishing trauma and complications. Given that over 1.2 million hernia procedures are performed annually in the U.S., LIQUIFIX provides accuracy and safety in delicate regions while lowering the risks of vascular or nerve injury.

Who Are The Major Companies Operating In The Ventral Hernia Treatment Market?

Major companies operating in the ventral hernia treatment market are Johnson And Johnson Services Inc., AbbVie, Abbott Laboratories, Medtronic Plc, Becton, Dickinson and Company (BD), Baxter International Inc., Braun Melsungen AG, Zimmer Biomet, Olympus Corporation, W.L. Gore and Associates Inc, STERIS Plc, Cook Medical Inc., KARL STORZ, Cooper University Health Care, Mölnlycke Health Care, Integra LifeSciences Holdings, ConMed Corporation, Aesculap Inc, Richard Wolf GmbH, Ethicon Inc, Tela Bio, Microline Surgical, Hernia Mesh S.R.L., Insightra Medical Inc, Advanced MedTech Solutions Pvt Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/ventral-hernia-treatment-global-market-report

How Do Regional Market Performances Compare Within The Ventral Hernia Treatment Industry?

North America was the largest region in the ventral hernia treatment market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the ventral hernia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Ventral Hernia Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21315&type=smp

Browse Through More Reports Similar to the Global Ventral Hernia Treatment Market 2025, By The Business Research Company

Hernia Repair Devices And Consumables Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hernia-repair-devices-and-consumables-global-market-report

Congenital Diaphragmatic Hernia Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/congenital-diaphragmatic-hernia-drugs-global-market-report

Hernia Mesh Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hernia-mesh-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795